David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$510M |
| 2 |
Bank of America
BAC
|
+$395M |
| 3 |
Meta Platforms (Facebook)
META
|
+$365M |
| 4 |
Costco
COST
|
+$351M |
| 5 |
Procter & Gamble
PG
|
+$347M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$573M |
| 2 |
Advanced Micro Devices
AMD
|
+$405M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$387M |
| 4 |
Walmart Inc
WMT
|
+$364M |
| 5 |
Amazon
AMZN
|
+$358M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.03% |
| 2 | Technology | 12.38% |
| 3 | Financials | 10.48% |
| 4 | Healthcare | 7.82% |
| 5 | Consumer Discretionary | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRY
2701
DELISTED
Berry Corp
BRY
| $2.52M | ﹤0.01% |
331,406
+266,038
| +407% | +$2.81M |
|
|
EBAC
2702
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
| $2.52M | ﹤0.01% |
258,174
| – | – |
|
2703
Fastenal
FAST
$58.5B
| $2.52M | ﹤0.01% |
100,982
+47,870
| +90% | +$1.29M |
|
2704
PUT
Winnebago Industries
WGO
$871M
| $2.52M | ﹤0.01% |
51,900
+18,400
| +55% | +$951K |
|
2705
PUT
AES
AES
$10.5B
| $2.52M | ﹤0.01% |
+119,700
| New | +$2.61M |
|
2706
ScottsMiracle-Gro
SMG
$3.53B
| $2.51M | ﹤0.01% |
31,827
-2,685
| -8% | -$265K |
|
2707
Waldencast
WALD
$174M
| $2.51M | ﹤0.01% |
255,147
| – | – |
|
2708
PagerDuty
PD
$977M
| $2.51M | ﹤0.01% |
101,366
-92,526
| -48% | -$2.54M |
|
2709
Kinross Gold
KGC
$38.5B
| $2.51M | ﹤0.01% |
701,286
-2,304,242
| -77% | -$11.1M |
|
2710
Visteon
VC
$2.75B
| $2.51M | ﹤0.01% |
24,230
-46,680
| -66% | -$4.82M |
|
|
LATG
2711
DELISTED
Chenghe Acquisition I Co. Class A Ordinary Shares
LATG
| $2.51M | ﹤0.01% |
248,825
+215,492
| +646% | +$2.14M |
|
2712
CALL
Wynn Resorts
WYNN
$9.9B
| $2.51M | ﹤0.01% |
44,000
-117,800
| -73% | -$7.79M |
|
2713
CALL
McCormick & Company Non-Voting
MKC
$14.5B
| $2.51M | ﹤0.01% |
30,100
-19,500
| -39% | -$1.85M |
|
2714
CALL
SLB Ltd
SLB
$79.6B
| $2.5M | ﹤0.01% |
70,000
-62,600
| -47% | -$2.61M |
|
|
FZT
2715
DELISTED
FAST Acquisition Corp. II
FZT
| $2.5M | ﹤0.01% |
255,967
| – | – |
|
|
PYCR
2716
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $2.5M | ﹤0.01% |
95,986
+79,264
| +474% | +$2.02M |
|
2717
MacroGenics
MGNX
$262M
| $2.5M | ﹤0.01% |
845,653
+605,055
| +251% | +$3.18M |
|
|
ZPTA
2718
DELISTED
Zapata Computing Holdings Inc. Common Stock
ZPTA
| $2.5M | ﹤0.01% |
250,000
+166,667
| +200% | +$1.66M |
|
|
GMFI
2719
DELISTED
Aetherium Acquisition Corp
GMFI
| $2.49M | ﹤0.01% |
251,117
+151,117
| +151% | +$1.5M |
|
2720
Atossa Therapeutics
ATOS
$26.6M
| $2.48M | ﹤0.01% |
151,976
-105,566
| -41% | -$1.66M |
|
|
SKYA
2721
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
| $2.48M | ﹤0.01% |
255,079
+88,520
| +53% | +$862K |
|
2722
PUT
Ubiquiti
UI
$35.6B
| $2.48M | ﹤0.01% |
10,000
| – | – |
|
2723
WaFd
WAFD
$2.64B
| $2.48M | ﹤0.01% |
82,610
-48,320
| -37% | -$1.52M |
|
|
EXPR
2724
DELISTED
Express, Inc.
EXPR
| $2.48M | ﹤0.01% |
63,199
+24,088
| +62% | +$1.45M |
|
|
DAWN
2725
DELISTED
Day One Biopharmaceuticals
DAWN
| $2.48M | ﹤0.01% |
+138,318
| New | +$1.43M |
|
Similar funds
David Shaw's Q2 2022 Portfolio in Review
As of Q2 2022, David Shaw held 6,080 positions worth $85.3B, down 20% from $107B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
David Shaw withdrew a net $9.17B in Q2 2022, closing 791 positions and reducing 1,835 holdings. Its most notable exit was Dominion Energy, Inc. 2019 Series A Corporate Units, an estimated $64.1M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 38% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in iShares MSCI Emerging Markets ETF worth $171M.
- David Shaw's largest Q2 2022 buy was iShares MSCI Emerging Markets ETF: 4,273,656 shares worth $171M.
- David Shaw added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2022, an estimated $510M increase.
- David Shaw's biggest Q2 2022 reduction was Marathon Petroleum, cutting an estimated $573M.
- David Shaw fully exited Dominion Energy, Inc. 2019 Series A Corporate Units in Q2 2022, selling an estimated $64.1M.
- David Shaw's ten largest holdings make up 8.5% of its $85.3B portfolio in Q2 2022.
- David Shaw opened 595 new positions and closed 791 in Q2 2022.
- David Shaw's portfolio value fell 20% quarter-over-quarter to $85.3B.
Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.